| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |